Feature Channels: Immunology

Filters close
Newswise: Training the immune system to prevent cancer – NextGen researchers discover paradigm-shifting approach
Released: 4-Dec-2023 6:05 PM EST
Training the immune system to prevent cancer – NextGen researchers discover paradigm-shifting approach
University of Missouri, Columbia

As one of the most insidious diseases in the world, cancer has few treatments that work to eradicate it completely. Now, a new ground-breaking approach pioneered by two researchers working at the University of Missouri’s Roy Blunt NextGen Precision Health building shows promising results in preventing lung cancer caused by a carcinogen in cigarettes — a discovery that immunologists Haval Shirwan and Esma Yolcu rank among the most significant of their careers.

Newswise: Could Our Body’s “Bleach” Be Key to Fighting a Common Fungal Pathogen?
Released: 4-Dec-2023 1:05 PM EST
Could Our Body’s “Bleach” Be Key to Fighting a Common Fungal Pathogen?
Stony Brook University

A study that assesses the effects of hypochlorous acid (HOCI), commonly known as bleach, as it is generated during the immune response of a cell (phagocytosis) when fighting a common fungal pathogen, Candida albicans, reveals that HOCI is a potent killing agent. The laboratory finding is highlighted in the journal mBio.

Released: 4-Dec-2023 11:05 AM EST
Entender el tratamiento con linfocitos T-CAR y sus posibles efectos secundarios
Mayo Clinic

La inmunoterapia aprovecha el sistema inmunitario del organismo para combatir el cáncer. El tratamiento con linfocitos T con receptor quimérico para el antígeno (tratamiento con linfocitos T-CAR) es una forma de inmunoterapia en la que los profesionales de atención médica extraen las células T de una persona (conocidas como linfocitos que participan en la respuesta del sistema inmunitario) y las modifican genéticamente para que produzcan receptores quiméricos para el antígeno. A continuación, estos linfocitos T-CARse reintroducen en el torrente sanguíneo del paciente, donde se dirigen a las células cancerosas y las destruyen.

Released: 1-Dec-2023 4:05 PM EST
فهم العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) وآثارها الجانبية المحتملة
Mayo Clinic

العلاج المناعي يسخر جهاز المناعة في الجسم لمحاربة السرطان. العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (العلاج بخلايا CAR-T) هو شكل من أشكال العلاج المناعي الذي يقوم فيه أخصائيو الرعاية الصحية بإزالة الخلايا التائية للشخص — خلايا الدم البيضاء المعروفة باسم الخلايا اللمفية التي تشارك في استجابة الجهاز المناعي — وتعديلها وراثيًا لإنتاج مستقبلات المستضد الخيمرية (CARs). يتم بعد ذلك حقن الخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) مرة أخرى في مجرى دم المريض، حيث تستهدف الخلايا السرطانية وتقتلها.

Newswise: Research Shows Human Behavior Guided by Fast Changes in Dopamine Levels
Released: 1-Dec-2023 9:05 AM EST
Research Shows Human Behavior Guided by Fast Changes in Dopamine Levels
Wake Forest University School of Medicine

A new study from researchers at Wake Forest University School of Medicine shows that dopamine release in the human brain plays a crucial role in encoding both reward and punishment prediction errors.

Released: 1-Dec-2023 7:05 AM EST
Hope for autoimmune skin disorder sufferers with new immunotherapy strategy
The Peter Doherty Institute for Infection and Immunity

Researchers, led by University of Melbourne’s Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute of Infection and Immunity (Doherty Institute), discovered distinct mechanisms controlling different types of immune cells, and found that, by precisely targeting these mechanisms, they could selectively eliminate ‘problematic cells’ and reshape the skin's immune landscape.

Newswise: Eating beans improves gut health, regulates immune and inflammatory processes in colorectal cancer survivors
30-Nov-2023 11:00 AM EST
Eating beans improves gut health, regulates immune and inflammatory processes in colorectal cancer survivors
University of Texas MD Anderson Cancer Center

Incorporating navy beans into the diet of colorectal cancer survivors has the potential to positively impact both gut and host health by modulating markers linked to obesity and disease, according to new research from The University of Texas MD Anderson Cancer Center.

Released: 30-Nov-2023 2:05 PM EST
Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ‘time toxicity’ for multiple myeloma treatments, what makes a ‘perfect’ graft — and much more
Fred Hutchinson Cancer Center

SEATTLE — Nov. 30, 2023 — The 65th Annual Meeting & Exposition of the American Society of Hematology (ASH) will take place in San Diego, Calif. and online Dec. 9-13.Below are highlights of Fred Hutchinson Cancer Center research to be presented and experts available to comment on news.

Released: 30-Nov-2023 2:05 PM EST
Harnessing the power of a parasite that can stop pain
Ohio State University

For the first time, scientists have begun to figure out why the disfiguring skin lesions caused by cutaneous leishmaniasis don’t hurt.

Newswise: November Research Highlights
Released: 30-Nov-2023 11:05 AM EST
November Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Newswise: Modular chimeric cytokine receptors improve CAR T–cell therapy for solid tumors
Released: 30-Nov-2023 11:05 AM EST
Modular chimeric cytokine receptors improve CAR T–cell therapy for solid tumors
St. Jude Children's Research Hospital

Adding a modular chimeric cytokine receptor to CAR T cells increased their efficacy. Learn how this modular system could improve brain and solid tumor therapy.

   
Released: 28-Nov-2023 11:05 AM EST
Study reveals hidden immune defense against cancer
University of California, Los Angeles (UCLA), Health Sciences

Researchers at the UCLA Jonsson Comprehensive Cancer Center have found certain immune cells can still fight cancer even when the cancer cells lack an important protein that the immune system relies on to help track down cancer cells.

Newswise: Bacteria, stay out!
Released: 28-Nov-2023 3:05 AM EST
Bacteria, stay out!
Empa, Swiss Federal Laboratories for Materials Science and Technology

Hospital germs and pathogens are not always transmitted directly from person to person. They can also spread via germ-contaminated surfaces and objects.

Newswise: Can a Novel Approach Lead to Less-Toxic Treatments for Leukemia?
Released: 27-Nov-2023 9:05 PM EST
Can a Novel Approach Lead to Less-Toxic Treatments for Leukemia?
Children's Hospital Los Angeles

Traditional cancer treatments such as chemotherapy and radiation can come with collateral damage. In the process of killing cancer, the treatments harm normal cells, too, leading to both short- and long-term side effects. Even today’s targeted drugs and immunotherapy can have effects on normal tissues.

Released: 27-Nov-2023 6:05 PM EST
Cellular postal service delivers messages from non-human cells, too
University of Connecticut

Messenger bubbles produced by human cells can pick up bacterial products and deliver them to other cells, University of Connecticut researchers report in the Nov. 16 issue of Nature Cell Biology.

   
Newswise: No IKAROS, no antibodies
Released: 27-Nov-2023 1:05 PM EST
No IKAROS, no antibodies
La Jolla Institute for Immunology

In a new Cell study, scientists at La Jolla Institute for Immunology (LJI) and Massachusetts General Hospital, Harvard Medical School, show how a protein called IKAROS helps "weave" the genome.

Newswise: American Association of Immunologists Wins IUIS 2023 Day of Immunology Campaign Award
Released: 27-Nov-2023 10:00 AM EST
American Association of Immunologists Wins IUIS 2023 Day of Immunology Campaign Award
American Association of Immunologists (AAI)

AAI announces it has been awarded the IUIS 2023 Day of Immunology Award for Best Theme

Released: 24-Nov-2023 10:05 AM EST
Nutrient found in beef and dairy improves immune response to cancer
University of Chicago Medical Center

Scientists at UChicago discover that trans-vaccenic acid (TVA), a fatty acid found in beef, lamb, and dairy products, improves the ability of immune cells to fight tumors.

Released: 22-Nov-2023 9:05 AM EST
Fighting AIDS: Why the goal is to diagnose HIV before symptoms appear
Mayo Clinic

HIV (human immunodeficiency virus), the virus that causes AIDS (acquired immunodeficiency syndrome), can hide in the body for many years before symptoms appear.

Released: 22-Nov-2023 9:05 AM EST
A luta contra a AIDS: por que é importante detectar o HIV antes que os sintomas apareçam
Mayo Clinic

O HIV (vírus da imunodeficiência humana) que causa a AIDS (síndrome de imunodeficiência adquirida) pode ficar oculto no corpo por muitos anos antes da manifestação dos sintomas.

Released: 22-Nov-2023 9:05 AM EST
La lucha contra el SIDA: por qué el objetivo es detectar el VIH antes de que aparezcan los síntomas
Mayo Clinic

El VIH (virus de la inmunodeficiencia humana), el virus que causa el SIDA (síndrome de inmunodeficiencia adquirida), se puede esconder en el organismo durante muchos años antes de que aparezcan los síntomas.

Released: 22-Nov-2023 1:05 AM EST
مكافحة مرض نقص المناعة البشري المكتسب (الإيدز): لماذا يكمن هدفنا في اكتشاف فيروس نقص المناعة البشري قبل ظهور الأعراض
Mayo Clinic

روتشستر، مينيسوتا – إن فيروس نقص المناعة البشري، الذي يسبب الإيدز (مرض نقص المناعة البشري المكتسب) بإمكانه أن يختفي في الجسم عدة سنوات قبلما تظهر الأعراض. وخلال هذا الوقت، فإنه يقضي على جزء من الجهاز المناعي دون أن نشعر. لذا فإن هدفنا هو اكتشاف فيروس نقص المناعة البشري قبلما تظهر الأعراض، مما يجعل الاختبارات الروتينية ضروريةً كي يعرف المرضى أنهم مصابون وكي يتسنى علاجهم، وهذا ما أوضحته الدكتورة ستيسي ريزا خبيرة الأمراض المُعدية والباحثة في فيروس نقص المناعة البشري لدى مايو كلينك.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Newswise: Cleveland Clinic Research Finds Sex Differences in  Immune Response and Metabolism Drive Alzheimer’s Disease
Released: 21-Nov-2023 11:05 AM EST
Cleveland Clinic Research Finds Sex Differences in Immune Response and Metabolism Drive Alzheimer’s Disease
Cleveland Clinic

Cleveland Clinic researchers analyzed genes and brain tissue of patients with Alzheimer’s and found that differences in brain immunometabolism – the interactions between the immune system and the ways cells create energy – may contribute to women’s increased risk for the disease and its severity.

Newswise: Promising target for CAR T cells helps cancer trick the immune system
Released: 21-Nov-2023 11:05 AM EST
Promising target for CAR T cells helps cancer trick the immune system
St. Jude Children's Research Hospital

Immunotherapy using modified chimeric antigen receptor (CAR) T cells has greatly improved survival rates for relapsed and recurrent pediatric leukemia and lymphomas, but not brain and solid tumors.

Newswise: Why natural allergen-specific antibodies cannot always protect against allergies
Released: 21-Nov-2023 8:05 AM EST
Why natural allergen-specific antibodies cannot always protect against allergies
Scientific Project Lomonosov

Immunologists found the difference between antibodies that react to birch pollen allergens in healthy people and patients with allergies. The authors also found out why not all classes of antibodies can protect against allergies. The results were published in Allergy.

Newswise: Seven LJI scientists rank among
Released: 17-Nov-2023 2:05 PM EST
Seven LJI scientists rank among "Highly Cited Researchers"
La Jolla Institute for Immunology

Clarivate calls these scientists "pioneers," noting that ranking on the Highly Cited Researchers list is a sign that a scientist has published significant findings and influenced their field of study.

Newswise: St. Jude scientists identify T-cell differentiation nodes to improve cancer-killing
Released: 15-Nov-2023 11:05 AM EST
St. Jude scientists identify T-cell differentiation nodes to improve cancer-killing
St. Jude Children's Research Hospital

St. Jude scientists mapped the gene regulatory networks responsible for progressive differentiation states of tumor-infiltrating T cells, using a technology known as single-cell CRISPR screening to knock out or genetically perturb multiple genes potentially involved.

Newswise: Icahn School of Medicine at Mount Sinai Secures $5 Million NIH Grant for Cutting-Edge Cancer Target Discovery and Development Center
Released: 15-Nov-2023 10:05 AM EST
Icahn School of Medicine at Mount Sinai Secures $5 Million NIH Grant for Cutting-Edge Cancer Target Discovery and Development Center
Mount Sinai Health System

The Department of Immunology and Immunotherapy and the Icahn Genomics Institute (IGI) at the Icahn School of Medicine at Mount Sinai have been awarded a $5 million grant from the National Cancer Institute (NCI) of the National Institutes of Health to establish a state-of-the-art center dedicated to the discovery and development of cutting-edge targets for cancer therapy.

Released: 15-Nov-2023 3:05 AM EST
Another step toward the HIV-1 vaccine: Dynamics of neutralizing antibodies
University of Cologne

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.

Newswise: Novel Immunotherapy Approach at Roswell Park Shows Promise in Metastatic Triple-Negative Breast Cancer
Released: 14-Nov-2023 1:05 PM EST
Novel Immunotherapy Approach at Roswell Park Shows Promise in Metastatic Triple-Negative Breast Cancer
Roswell Park Comprehensive Cancer Center

A phase 1 clinical trial conducted exclusively at Roswell Park Comprehensive Cancer Center shows that a novel treatment regimen can make immunotherapy more effective in patients with metastatic triple-negative breast cancer (mTNBC).

Newswise: 20231110_Allison_Institute_Symposium.jpg
Released: 14-Nov-2023 12:05 PM EST
Allison Institute hosts inaugural scientific symposium
University of Texas MD Anderson Cancer Center

The James P. Allison Institute at MD Anderson hosted its inaugural scientific symposium on Nov. 10, bringing together more than 400 leading scientists in immunotherapy and immunobiology.

   
Newswise: Researchers Explore Origins of Lupus, Find Reason for Condition’s Prevalence Among Women
Released: 14-Nov-2023 10:00 AM EST
Researchers Explore Origins of Lupus, Find Reason for Condition’s Prevalence Among Women
Johns Hopkins Medicine

For years, researchers and clinicians have known that lupus, an autoimmune condition, occurs in women at a rate nine times higher than in men.

Newswise: Cancer stem cells trigger macrophage aging
7-Nov-2023 7:00 PM EST
Cancer stem cells trigger macrophage aging
Hokkaido University

Cancer stem cells cause the aging of macrophages in mice with healthy immune systems, creating conditions for the formation of tumors.

13-Nov-2023 5:05 PM EST
New Antiphospholipid Syndrome Research Findings Presented at ACR Convergence 2023
Hospital for Special Surgery

Investigators from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) presented new research findings in antiphospholipid syndrome (APS) at the American College of Rheumatology (ACR) Convergence 2023, the ACR’s annual meeting.

Released: 10-Nov-2023 12:05 PM EST
Gwen Fortune-Blakely Named Chief Membership and Engagement Officer of The American Association of Immunologists
American Association of Immunologists (AAI)

The American Association of Immunologists (AAI) is pleased to announce the appointment of Gwen Fortune-Blakely, M.B.A, CAE, as its new chief membership and engagement officer.

Newswise: New Knowledge Commons to improve understanding of immune system
Released: 9-Nov-2023 2:05 PM EST
New Knowledge Commons to improve understanding of immune system
UT Southwestern Medical Center

UT Southwestern Medical Center will lead a multi-institution effort to gather and assimilate information on the billions of sequences employed by immune receptors of the adaptive immune system. The project, funded by the National Institutes of Health, aims to improve the understanding of immunity and help facilitate the development of improved vaccines and treatments for many diseases.

Newswise: What Human Diseases Can Teach Us About the Immune System
Released: 9-Nov-2023 1:05 PM EST
What Human Diseases Can Teach Us About the Immune System
Harvard Medical School

Jennifer Oyler-Yaniv is studying human diseases to learn about the immune system. She hopes that diseases such as cancer will reveal fundamental principles of how immune cells communicate

8-Nov-2023 4:05 PM EST
Sylvester research shows how interactions between tumor genes and microenvironment influence treatment response in multiple myeloma
Sylvester Comprehensive Cancer Center

A multicenter study led by researchers at Sylvester Comprehensive Cancer Center shows how interactions between tumor cells and immune components of the microenvironment can impact treatment responses and outcomes in patients newly diagnosed with multiple myeloma who undergo combination treatments that include targeted immunotherapy.

Newswise: Nuevo estudio: hacer gárgaras con agua salada podría ayudar a prevenir la hospitalización por COVID
3-Nov-2023 8:00 AM EDT
Nuevo estudio: hacer gárgaras con agua salada podría ayudar a prevenir la hospitalización por COVID
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presentará en la Reunión Científica Anual del ACAAI de este año en Anaheim (California) determinó que tanto un régimen de solución salina de dosis baja como de dosis alta parecían estar asociadas a menores tasas de hospitalización en comparación con los controles en las infecciones por SARS-CoV-2.

Newswise: Una encuesta revela que el 42 % de los médicos de atención primaria no están familiarizados con los productos biológicos para tratar el asma
3-Nov-2023 8:00 AM EDT
Una encuesta revela que el 42 % de los médicos de atención primaria no están familiarizados con los productos biológicos para tratar el asma
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presentará en la Reunión Científica Anual del ACAAI de este año en Anaheim (California) muestra que el 42% de los médicos de atención primaria (PCP) encuestados no estaban familiarizados con los productos biológicos para tratar el asma.

Newswise: Survey Reveals 42% of Primary Care Physicians Are Unfamiliar with Biologics to Treat Asthma
3-Nov-2023 8:00 AM EDT
Survey Reveals 42% of Primary Care Physicians Are Unfamiliar with Biologics to Treat Asthma
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting in Anaheim, Calif. shows that 42% of the primary care physicians (PCPs) surveyed were unfamiliar with asthma biologics.

Newswise: Special Toothpaste May Lower Risk of Allergic Reactions for Adults with Peanut Allergy
3-Nov-2023 8:00 AM EDT
Special Toothpaste May Lower Risk of Allergic Reactions for Adults with Peanut Allergy
American College of Allergy, Asthma and Immunology (ACAAI)

A new late breaking abstract being presented at this year’s ACAAI Annual Scientific Meeting in Anaheim, Calif. demonstrates that a specially formulated toothpaste can be successfully used for Oral Mucosal Immunotherapy (OMIT).

Released: 9-Nov-2023 8:00 AM EST
Vigorous Exercise, Rigorous Science: What Scientists Learned from Firefighters in Training
Pacific Northwest National Laboratory

PNNL scientists took thousands of measurements of firefighters in training to learn more about how the body responds to vigorous exercise.



close
2.36195